Please login to the form below

Not currently logged in
Email:
Password:

Agios Pharma

This page shows the latest Agios Pharma news and features for those working in and with pharma, biotech and healthcare.

Servier to acquire Agios’ oncology business in $1.8bn deal

Servier to acquire Agios’ oncology business in $1.8bn deal

French pharma will also gain Agios' oncology-associated employees. French pharma Servier has announced that it will acquire Agios Pharmaceuticals’ oncology business unit which includes it entire commercial, clinical and ... Agios already markets its

Latest news

  • Orphan drugs dominate FDA's record-breaking year Orphan drugs dominate FDA's record-breaking year

    drugs, driven on by new pharma and biotech science, and the FDA's determination to accelerate its review times. ... There were also a number of drugs with brand new mechanisms of action, including three CGRP inhibitors for migraine prevention from Amgen,

  • Celgene, Agios get FDA OK for leukaemia drug Idhifa Celgene, Agios get FDA OK for leukaemia drug Idhifa

    Duo’s drug becomes first new AML therapy since Novartis' Rydapt. Celgene and Agios Pharma have claimed FDA approval for Idhifa, a new drug that is targeted at patients with a ... That kicked off in 2010 with a $130m upfront payment from Celgene to Agios

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Agios appoints Celgene’s Jackie Fouse Agios appoints Celgene’s Jackie Fouse

    She joins the pharma group’s board of directors. Cancer and rare genetic disease focused group Agios Pharmaceuticals has appointed Jackie Fouse to its board of directors as the company prepares ... growing biotechnology company, so we are thrilled to

  • Chris Bowden joins Agios Chris Bowden joins Agios

    He is former VP, product development oncology at Genentech. Agios Pharma has named former Genentech VP Chris Bowden as chief medical officer. ... Bowden's knowledge of oncology will benefit Agios as it prepares to advance the development of three

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...